Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Chronic Illness

erlotinib hydrochloride has been researched along with Chronic Illness in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koskinen, PK; Palin, N; Rintala, JM; Rintala, SE; Savikko, J; von Willebrand, E1
Koskinen, P; Rintala, JM; Rintala, S; Savikko, J1
Camidge, DR; Erickson, TM; Koeppe, JR; Miller, YE; Stuart, RW1
Herzog, M; Hosemann, W; Kaftan, H; Lempas, K; Vogelgesang, S1

Other Studies

4 other study(ies) available for erlotinib hydrochloride and Chronic Illness

ArticleYear
Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
    Transplantation, 2014, Oct-27, Volume: 98, Issue:8

    Topics: Animals; Aorta; Chronic Disease; Epidermal Growth Factor; Erlotinib Hydrochloride; Graft Rejection; Immunohistochemistry; Kidney; Kidney Transplantation; Male; Quinazolines; Rats; Rats, Wistar; Transplantation, Homologous

2014
Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte-macrophage function in vitro.
    Transplant immunology, 2015, Volume: 32, Issue:3

    Topics: Animals; Cell Differentiation; Cell Line; Cell Movement; Cell Proliferation; Chronic Disease; Coronary Vessels; Endothelium, Vascular; ErbB Receptors; Erlotinib Hydrochloride; Graft Rejection; Humans; Macrophages; Monocytes; Myocytes, Smooth Muscle; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Rats

2015
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:11

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Chronic Disease; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Female; HIV; HIV Infections; Humans; Lung Diseases, Interstitial; Middle Aged; Mutation; Prognosis; Protein Kinase Inhibitors; Quinazolines

2008
Inhibition of epidermal growth factor receptor by erlotinib: wound healing of experimental tympanic membrane perforations.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2007, Volume: 28, Issue:2

    Topics: Animals; Chronic Disease; ErbB Receptors; Erlotinib Hydrochloride; Protein Kinase Inhibitors; Quinazolines; Rats; Tympanic Membrane Perforation; Wound Healing

2007